Patient characteristics | All patients | Patients with TOE positive for IE |
Number of patients, n (%) | 160 (100) | 44 (28) |
Age, mean (SD), median (IQR) | 60.0 (16.4); 63.0 (20.5) | 58.7 (19.7); 64.5 (30.5) |
Female, n (%) | 68 (42) | 19 (43) |
Male, n (%) | 92 (58) | 25 (57) |
Age of females, mean (SD); median (IQR) | 55.7 (18.4) | 51.2 (21.1); 55.0 (44.0) |
Age of males, mean (SD); median (IQR) | 63.1 (14.1) | 65.9 (15.0); 72.0 (16.0) |
Clinical characteristics | All patients | Patients with TOE positive for IE |
Diabetes mellitus | 5 (3) | 3 (7) |
Chronic kidney disease | 8 (5) | 5 (11) |
Cancer | 33 (21) | 7 (16) |
Major Duke criteria | n (% of all patients) | n (% of patients with TOE positive for IE) |
Positive blood culture, n (%) | 105 (66) | 33 (75) |
Gram positive bacteria | 87 (54) | 26 (59) |
Staphylococcus aureus | 48 (30) | 16 (36) |
Streptococci | 8 (5) | 2 (5) |
CoNS | 5 (3) | 2 (5) |
Candida | 3 (2) | 1 (2) |
Enterococci | 5 (3) | 2 (5) |
Negative blood culture, n (%) | 22 (14) | 4 (9) |
Unknown result from blood culture, n (%) | 33 (21) | 7 (16) |
Positive TOE, n (%) | 44 (28) | |
Aortic valve | 15 (9) | |
Mitral valve | 23 (14) | |
Tricuspid valve | 2 (1) | |
Pulmonary valve | 1 (1) | |
Dishiscence of prosthetic valve, n (%) | 1 (1) | |
Abscess, n (%) | 2 (1) | |
18FDG PET/CT, n (%) | 21 (13) | 8 (18) |
18FDG PET/CT positive for IE, n (%) | 4 (3) | 1 (2) |
Minor criteria | ||
Predisposing factors | ||
Intravenous drug use | 5 (3) | 2 (5) |
Predisposing heart condition (excl. CIED and prosthetic valves) | 4 (3) | 4 (9) |
CIED | 4 (3) | 3 (7) |
Prosthetic valve (-s) | 33 (21) | 14 (32) |
TAVR | 14 (9) | 6 (14) |
bAVR | 7 (4) | 3 (7) |
mAVR | 5 (3) | 1 (2) |
bMVR | 1 (1) | 0 (0) |
Pulmonary homograft | 5 (3) | 1 (2) |
Freestyle aortic root | 1 (1) | 0 (0) |
mAVR + mMVR | 1 (1) | 0 (0) |
Fever (> 38 C) | 97 (61) | 31 (70) |
Vascular phenomena, n (%) | 20 (13) | 7 (16) |
Immunological phenomena, n (%) | 0 (0) | 0 (0) |